Edinburgh, United Kingdom

Debiao Zhao

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Geron Corporation, The University of Edinburgh. Active years: 2012.



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Debiao Zhao: Innovator in Stem Cell Research

Introduction

Debiao Zhao is a prominent inventor based in Edinburgh, GB. He has made significant contributions to the field of stem cell research, particularly in the differentiation of pluripotent cells. His innovative methods have the potential to advance medical science and therapeutic applications.

Latest Patents

Debiao Zhao holds a patent titled "Differentiation of primate pluripotent cells to hepatocyte-lineage cells." This patent provides methods for differentiating primate pluripotent stem cells into hepatocyte-lineage cells. The methods utilize sequential culturing of the primate pluripotent stem cells in specific growth factors to produce hepatocyte-lineage cells. Additionally, the population of cells produced by these methods can be further enriched for hepatocyte-lineage cells. He has 1 patent to his name.

Career Highlights

Throughout his career, Debiao Zhao has worked with notable organizations, including Geron Corporation and the University of Edinburgh. His work has been instrumental in advancing the understanding and application of stem cell technology.

Collaborations

Debiao Zhao has collaborated with esteemed colleagues such as David Colin Hay and Anish Sen Majumdar. These collaborations have further enriched his research and contributed to the scientific community.

Conclusion

Debiao Zhao's innovative work in stem cell differentiation showcases his commitment to advancing medical science. His contributions are paving the way for future breakthroughs in regenerative medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…